GNSS Chip Market 2022 Future Analysis, Demand by Regions and Opportunities with Challenges 2032

The global GNSS Chip Market sector is expanding rapidly, fuelled by increased demand from the semiconductor and electronics industries. As of 2022, the market’s projected worth was an astounding US$ 5.2 billion, with estimates predicting a significant growth to US$ 9.7 billion in 2032. This amazing growth is largely due to the expanding prospects given by the GNSS chip sector.

In terms of accuracy and quantity of satellites, GNSS chips outperform GPS. It may receive signals from several satellite navigation systems, whereas GPS chips only accept GPS signals and provide location.

For example, if a GPS chip is obstructed by a tall building or a mountain, it may find it difficult to receive signals from enough satellites to determine its position accurately. On the contrary, in case of a GNSS chip, it can receive signals from other satellite navigation systems and determine the user’s position more accurately.

To meet this objective, manufacturers are focusing on improving the accuracy of GNSS chips by increasing the sensitivity of indoor signals. This new development will facilitate accurate results for indoor positioning and navigation, making GNSS chips an attractive choice for customers.

One key application of GNSS chip technology in Industry 4.0 is in the area of asset tracking and management.

By using GNSS chips, automotive manufacturers can track the location of vehicles and components throughout the production process. This information can be used to optimize production schedules, reduce lead times, and improve inventory management.

GNSS chips can be used in automotive predictive maintenance to monitor vehicle performance in real-time. This helps manufacturers to identify potential issues before they become critical, which reduces downtime and improves product reliability.

Key Takeaways from GNSS Chip Market

  • The global GNSS chip market exhibited a moderate CAGR of around 7.5% during the historical period 2017 to 2021.
  • Asia Pacific GNSS chip market is projected to be worth US$ 4.9 billion in 2032.
  • The USA GNSS chip market is set to create an absolute $ growth of US$ 574.5 million till 2032.
  • Based on device, the smartphone segment is anticipated to steadily grow at a CAGR of 6.4% from 2022 to 2032.
  • Based on vertical, the automotive segment witnessed prominent growth at a CAGR of 7.0% from 2017 to 2021.

“As manufacturers adopt GNSS technology for predictive maintenance and autonomous driving applications, the automotive vertical will prove to become a high revenue earning segment.” – Says a lead analyst.

Competitive Landscape: GNSS Chip Industry

The top market players in the industry are exploring innovative ways to deliver high-quality goods and expanding their product lines. This includes focusing on patenting innovations and broadening product portfolios to stay ahead of competition.

Key Players

  • Qualcomm Incorporated
  • STMicroelectronics NV
  • Mediatek Inc.
  • U-Blox Holding
  • Broadcom Limited
  • Intel Corporation

For instance,

  • In June 2022, the high-performance single-band ultra-low power GNSS positioning module LC76G was launched by a Chinese company—Quectel.

The LC76G is a GNSS chip that comes with an inbuilt SAW filter and an integrated LNA. It can be directly attached to a passive patch antenna, and it offers a filter against unwanted interference. As a result, the LC76G provides great performance, even while driving through crowded urban canyons.

Get More Exclusive Insights into GNSS Chip Market Study

Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the GNSS Chip Industry , presenting historical market data (2017 to 2021) and forecast statistics for the period from 2022 to 2032.

The study reveals extensive growth in the GNSS Chip Industry in terms of device (smartphones, tablets, personal navigation devices, and in-vehicle systems), application (navigation, mapping, surveying, location-based services, telematics, and timing and synchronization), vertical (consumer electronics, construction, agriculture, automotive, military, and defense, marine, and transport) and region.

GNSS Chip Market Outlook by Category

By Device:

  • Smartphones
  • Tablets
  • Personal Navigation Devices
  • In-vehicle Systems

By Application:

  • Navigation
  • Mapping
  • Surveying
  • Location-based Services
  • Telematics
  • Timing and Synchronization

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

By Vertical:

  • Consumer Electronics
  • Construction
  • Agriculture
  • Automotive
  • Military and Defense
  • Marine
  • Transport

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Thermal Labels Market to Reach USD 1,494.64 Million by 2033, Driven by Growing Demand Across Industries

Thermal Labels Market

The global thermal labels market is projected to experience robust growth over the next decade, with market value expected to reach USD 1,494.64 million by 2033. Starting from an estimated value of USD 935.24 million in 2023, the market is set to grow at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2033.

According to FMI analysis, the market was valued at USD 851.5 million in 2021 and is projected to reach USD 1,420.5 million by the end of 2032. The top three countries are expected to account for 45% to 50% of the global market share in 2023, indicating strong regional demand.

Key Factors Driving Market Growth

  1. Regulatory Compliance and Information Printing:
    • Increasing regulatory requirements for product information on packaging are boosting the demand for thermal labels. Governments worldwide mandate the display of critical information on product packages, driving industries to adopt efficient labeling solutions.
  2. Heat and Moisture Resistance:
    • Thermal labels are gaining traction due to their ability to withstand heat and moisture, making them suitable for diverse industrial applications. This durability enhances their appeal in sectors requiring robust labeling solutions.
  3. E-commerce and Retail Expansion:
    • The surge in e-commerce and retail activities is significantly boosting the demand for thermal labels. Reliable and efficient labeling processes are crucial for tracking, bar-coding, and identifying product information, driving market growth.
  4. Food & Beverage Industry:
    • The food & beverage sector’s growing need for proper labeling of perishable items is a major market driver. Rising global population and demand for convenience foods further propel market revenue.
  5. Healthcare and Pharmaceutical Sector:
    • The healthcare industry is increasingly adopting thermal labels to manage inventory, track medical devices, and ensure patient safety. This sector’s stringent regulatory requirements necessitate precise and durable labeling solutions.

Trends Shaping the Thermal Labels Market

  1. Logistics and Warehousing:
    • The logistics and warehousing sectors are rapidly adopting thermal labels for packaging, warehousing, international trade, and supply chain management. The expansion of e-commerce and online services is a key factor driving this trend.
  2. Advanced Printing Technologies:
    • Innovations in thermal label printing technologies are enhancing print quality and durability, attracting end-users who seek to promote their products effectively. These advanced technologies support high-quality, durable labeling solutions.
  3. Sustainable and Eco-friendly Labels:
    • The growing focus on sustainability is prompting the development of recyclable thermal labels. End-user industries are increasingly adopting eco-friendly labels to reduce environmental impact, aligning with consumer preferences for sustainable products.

Market Trends

  • Increasing demand for durable and sustainable labels
  • Rising popularity of direct thermal labels
  • Focus on eco-friendly and recyclable solutions

Opportunities Ahead

  • Growing investments in thermal label technology
  • Expansion of e-commerce and retail sectors
  • Government initiatives for carbon emission reduction
  • Continued research and development activities

Regional Growth Prospects

The US Market: A Leading Force

The United States is expected to hold a significant share (around 19%) of the global thermal label market by 2033, driven by factors like busy lifestyles and the convenience food trend. A projected CAGR of 3.7% further reinforces the US market’s strong position.

India: A Promising Market

India’s thermal label market is poised for impressive growth, with a projected CAGR of 5.4% from 2023 to 2033. The country’s expanding food & beverage sector, readily available raw materials, and access to labor are key drivers of this growth.

Access Full Report: 
Thermal Labels Market by Category

By Material:

  • Paper
  • Plastic

By Label:

  • Direct thermal labels
  • Thermal transfer labels

By Application:

  • Food & beverages
  • Healthcare
  • Semiconductor & Electronics
  • Others (Industrial)

By Region:

  • North America
  • Latin America
  • Europe
  • Middle east and Africa
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

LED Grow Lights Market 2022 Future Analysis, Demand by Regions and Opportunities with Challenges 2032

The global LED Grow Lights Market witnessed a substantial surge in 2021, reaching a value of US$ 1.5 billion. Projections for the next decade indicate an impressive Compound Annual Growth Rate (CAGR) of 22.7%, propelling the total market size from US$ 1.9 billion in 2022 to a staggering US$ 14.8 billion by the end of 2032. This remarkable growth is attributed to various key factors driving the market forward.

An electric light source known as a grow lamp assists in stimulating plant growth in small areas. Grow lights increase crop yield in regions where the lack of or insufficient availability of sunlight causes the climatic conditions to be unsuitable for the plants.

To Get Sample Copy of Report Visit :
https://www.futuremarketinsights.com/reports/sample/rep-gb-8115

Due to their superior energy efficiency when compared to conventional grow lights such as high-pressure sodium (HPS) and metal halide (MH) lamps, LED grow lights are becoming increasingly popular.

By using LED grow lights, farmers can significantly improve yield and lower costs. Growers pay less for electricity because LED grow lights use less energy to generate the same amount of light.

Additionally, LED grow lights can be modified to emit only the precise wavelengths of light that plants require for optimum growth. As a result, growers are able to customize their lighting systems to meet the unique requirements of their crops.

There is a rising need for food that can be grown in carefully regulated indoor environments as the world’s population continues to rise. The demand for LED grow lamps is rising as indoor farming systems and greenhouses increasingly rely on these lights.

Key Takeaways from the LED Grow Light Market Report:

  • Global sales of LED grow lights are set to rise at 22.7% CAGR during the forecast period.
  • By product, <300 watt LED grow lights demand will rise at 22.6% CAGR over the next ten years.
  • By installation type, new installation segment is likely to progress at 22.5% CAGR through 2032.
  • The USA LED grow light market valuation will exceed US$ 2.4 billion by 2032.
  • China LED grow light market size is set to reach US$ 3.8 billion by 2032
  • Demand for LED grow lights in Korea is set to increase at 23.2% CAGR over the next ten years.
  • Japan’s LED grow light industry will cross a valuation of US$ 2.3 billion by the end of 2032.

“Transition towards indoor farming techniques to meet growing food demand will boost the market. Further, development of more advanced products with better efficiencies will bode well for the market. Says a Future Market Insights analyst.

Who is Winning?

Leading LED grow light manufacturers include Osram Licht AG, Royal Philips Electronics N.V., General Electric Company, Lumigrow, Inc., Heliospectra AB, SMART Global Holdings, Illumitex, Inc., Inc., Everlight Electronics Co. Ltd., Petronas Bridgelux, Inc., and Royal Dutch Shell plc,

To meet end user demand, these companies are focusing on introducing new LED grow lights with better efficiencies. For instance,

  • In July 2022, AB lighting announced the launch of AB 330 and AB 660. The new line of grow light optimizes power consumption and helps growers reach higher yields.

More Insights Available:

Future Market Insights, in its new offering, presents an unbiased analysis of the LED glow light market presenting historical data (2017 to 2021) and forecast statistics for the period from 2022 to 2032.

The study reveals growth projection in terms of product (less than 300 and more than 300), installation type (retrofit and new installations), and application (indoor farming, commercial greenhouse, vertical farming, turf and landscaping, and research) across various regions.

Drive Success with Data: Purchase Your Copy of the Report Here

Global LED Grow Light Market Segmentation

By Product:

  • Less than 300 Watts
  • More than 300 Watts

By Installation Type:

  • Retrofit
  • New Installation

By Application:

  • Indoor Farming
  • Commercial Greenhouses
  • Vertical Farming
  • Turf and landscape
  • Research

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Interleukin-6 (IL-6) Inhibitors Market Projected to Surge to USD 93.3 Billion by 2033, Growing at a 10.9% CAGR

Interleukin-6 (IL-6) Inhibitors Market
Interleukin-6 (IL-6) Inhibitors Market

The global interleukin-6 (IL-6) inhibitors market is set for remarkable growth, with its value expected to rise from USD 33.3 billion in 2023 to USD 93.3 billion by 2033. This anticipated expansion represents a compound annual growth rate (CAGR) of 10.9% over the forecast period, according to recent research by Future Market Insights.

At the end of 2022, the IL-6 inhibitors market was valued at USD 30.2 billion and is projected to exhibit a year-on-year (Y-o-Y) growth of 10.2% in 2023. This rapid growth underscores the increasing demand for IL-6 inhibitors driven by their effectiveness in treating a range of inflammatory and autoimmune conditions.

According to the World Health Organization, the globally 18% of women of above 80 years and 9.6% of men are suffering from arthritis. The American Cancer Society has stated the surge of 4,300 to 5,100 of CD in the U.S.  Coronavirus has surged the market of Interleukin-6 (IL-6) inhibitors with its demands to ameliorate severe pneumonia, alveolar damages. Tocilizumab and Sarilumab are in active use against Coronavirus and siltuximab are under investigation.

Current augmentations of improving healthcare industry, increasing therapeutic demands, active development of Interleukin-6 (IL-6) inhibitors and Coronavirus anticipates for the further future growth of global Interleukin-6 (IL-6) inhibitors.

Interleukin-6 (IL-6) Inhibitors Market: Drivers and Restraints:

The driver of global Interleukin-6 (IL-6) inhibitors market includes the high target specificity and affinity of Interleukin-6 (IL-6) inhibitors and its availability, rising cases of rheumatoid arthritis, Castleman’s disease, cancer, arteritis and several other autoimmune and inflammatory diseases.

The global Interleukin-6 (IL-6) inhibitors market drivers include the availability of highly specific and efficient Interleukin-6 (IL-6) inhibitors, increasing autoimmune diseases and cancer, raising awareness, key market players, advancing research and healthcare expenditures.

The available Interleukin-6 (IL-6) inhibitors are highly efficient and target specific. Interleukin-6 (IL-6) inhibitors are primarily used for the treatment of Rheumatoid Arthritis, Castleman’s disease and cancers. The positive outcomes of R&D, clinics trials and FDA approvals potentiate the lucrative growth spurt of Interleukin-6 (IL-6) inhibitors market, supported by government aids and awareness campaigns.

The manufactures and vendors are working with the key focus of improved efficacy, target specificities of the Interleukin-6 (IL-6) inhibitors, also strategic collaborations and alliances, and biologic development in the Interleukin-6 (IL-6) inhibitors domain are propelling the market.

However, the global Interleukin-6 (IL-6) inhibitors market decelerates by the adverse reactions, high cost and stringent regulations. Despite these restraints, the global Interleukin-6 (IL-6) inhibitors market is poised to grow lucratively by the supportive reimbursement policies for cutting down the cost and expenses, and the several potential including Olokizumab, Elsilimomab, Sirukumab, Clazakizumab and many more.

Interleukin-6 (IL-6) Inhibitors Market: Overview

The global Interleukin-6 (IL-6) inhibitors market is poised to grow at a lucrative rate by the rising autoimmune diseases, improved Interleukin-6 (IL-6) inhibitors and advancing healthcare and research.

By disease type, Rheumatoid Arthritis dominates the segment with its rising cases and the active use of Interleukin-6 (IL-6) inhibitors (Tocilizumab) for treatment. By Interleukin-6 (IL-6) inhibitors type, the Tocilizumab rules the segment with its massive application for Rheumatoid arthritis, Systemic juvenile idiopathic arthritis Castleman’s disease (CD), giant cell arteritis and lung carcinomas.

Siltuximab segment is growing at a faster rate with its application for prostate cancer, renal cancer and CD. By distribution channels type, retail pharmacies segment holds the largest market of Interleukin-6 (IL-6) inhibitors distributions, driven by its convenience, drug availability and increasing numbers of retail pharmacies globally.

Interleukin-6 (IL-6) Inhibitors Market: Key players

The key players of global Interleukin-6 (IL-6) inhibitors market include:

  • Roche
  • Sanofi
  • GlaxoSmithKline
  • Janssen
  • Tiziana Life Sciences
  • Regeneron
  • Novimmune
  • Vitaeris and Chugai Pharmaceutical.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.The report also maps the qualitative impact of various market factors on market segments and geographies.

Interleukin-6 (IL-6) Inhibitors Market: Segmentation:

he global Interleukin-6 (IL-6) inhibitors market is segmented into diseases, IL-6 inhibitors types, distribution channels and regions.

Disease Type:

  • Rheumatoid Arthritis
  • Castleman’s disease
  • Cancers (Renal cancer, prostate cancer )
  • Arteritis

IL-6 inhibitors Types:

  • Tocilizumab
  • Siltuximab
  • Sylvant

Distribution Channels:

  • Retail Pharmacies
  • Hospital pharmacies
  • Online pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cardiovascular Diagnostics Market Set to Reach USD 9.7 Billion by 2033, Growing at a 5.1% CAGR

Global Cardiovascular Diagnostics Industry
Cardiovascular Diagnostics Market

The global cardiovascular diagnostics market is on track for substantial growth, with projections indicating an increase from USD 5.9 billion in 2023 to USD 9.7 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 5.1% over the forecast period, according to recent research by Future Market Insights.

At the end of 2022, the market was valued at USD 5.6 billion and is expected to exhibit a year-on-year (Y-o-Y) growth of 4.3% in 2023. This upward trend underscores the rising demand for advanced diagnostic solutions driven by increasing cardiovascular disease prevalence, technological advancements, and a growing focus on early detection and personalized medicine.

The market experienced growth in 2021, surpassing initial projections before the COVID-19 pandemic. Since the emergence of COVID-19 three years ago, the disease has affected over 750 million individuals worldwide. Recent studies have indicated that certain individuals who have contracted COVID-19 are at a higher risk of developing cardiovascular conditions like irregular heartbeat, stroke, and heart failure.

The connection between COVID-19 and cardiovascular disease has been observed, highlighting the potential long-term impact of the virus on cardiovascular health. This correlation emphasizes the importance of addressing and monitoring the cardiovascular health of individuals who have had COVID-19, as well as the need for continued research and advancements in cardiovascular diagnostics and treatments to mitigate the potential consequences of the disease. Overall, the cardiovascular diagnostic market is likely to expand in the next years, offering a cost-effective and simple option for patients suffering from CVDs.

Key Takeaways from this Market:

  • Electrocardiogram (ECG) systems hold a significant market share of 43.4% in the global cardiovascular diagnostics market in 2022 due to the prominence of ECG systems globally.
  • Hospitals take away the larger share among all end users due to the availability of most diagnostic products and equipment in the hospitals. The segment held around 30.5% value share in 2022.
  • The North American region accounts for the dominant market share at 37.4%, with a market value of US$ 2.1 Billion in 2022 owed to the strong market presence of key players in North America contributing to the overall advancement and expansion of the cardiovascular diagnostics market.

“The increasing global prevalence of the cardiovascular disease has led to a growing demand for CVD diagnostics in recent years, this presents a favourable opportunity for entry into the cardiovascular disease diagnostic market,” – says an analyst at Future Market Insights (FMI).

Market Competition:

The cardiovascular diagnostic industry is extremely competitive, with GE Healthcare and Abbott Laboratories among the leading participants. To achieve a greater market share, these firms are continually reinventing their goods and marketing techniques, with an emphasis on price, convenience, and efficacy.

  • In February 2023, GE HealthCare aims to revolutionize ultrasounds by making them accessible worldwide, as demonstrated by their recent acquisition of Caption Health, an AI software company specializing in cardiac imaging.
  • In September 2022, SRL Diagnostics introduces ‘Heart Assure’, a specialized blood test using high-sensitivity Troponin I to accurately predict the risk of cardiac events.

Key Players:

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Schiller, Koninklijke Philips N.V.
  • GE Healthcare and Wayra
  • Siemens Healthcare
  • Lepu Medical
  • Midmark Corp
  • Roche Ltd
  • Randox Laboratories Ltd.
  • Robonik India
  • Diasorin
  • Elabscience Biotechnology

A Old Full Report Analysis Click Here

Key Market Segmentation:

By Product:

  • Electrocardiogram (ECG) system
  • Resting ECG Systems
  • Cardiopulmonary Stress Testing Systems
  • Holter Monitoring Devices
  • Event Monitoring Devices
  • Implantable Loop Recorder (ILR)
  • Others

By Point-of-Care Testing:

  • Analyzers
  • Lipoprotein Test Kits
  • Angiotensin Test Kits
  • Fibrinogen Test Kits
  • Serum Uric Acid Test Kits
  • High-Sensitivity CRP (hs-CRP) Kits

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Cardiac Catheterization Labs
  • Diagnostic Imaging Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

USA Knotless Surgical Sutures Market Projected to Reach USD 258.7 Million by 2033, Growing at a 3.6% CAGR

USA Knotless Surgical Sutures Industry
USA Knotless Surgical Sutures Industry

The USA knotless surgical sutures market is on a steady growth trajectory, with projections indicating an increase from USD 181.0 million in 2023 to USD 258.7 million by 2033. This growth represents a compound annual growth rate (CAGR) of 3.6% over the forecast period, according to recent research by Future Market Insights.

At the end of 2022, the market for knotless surgical sutures was valued at USD 175.7 million and is anticipated to exhibit a year-on-year (Y-o-Y) growth of 3.1% in 2023. This positive trend reflects the growing adoption of knotless sutures in surgical procedures due to their advantages in reducing surgical time and improving patient outcomes.

In July 2022, Dolphin Sutures launched a range of antibacterial sutures to reduce surgical site infection prevalence.

The rise in disposable income is expected to be another important factor driving the growth of the Knotless Surgical Sutures market. Increasing disposable income enables an excellent growth opportunity for surgical suture manufacturers to connect with potential end users.

Rising disposable income can fuel investments in research and development within the healthcare industry. Higher disposable income enables companies to invest in innovation, improving the quality and effectiveness of Knotless Surgical Sutures.

These factors are fueling the expansion of the USA Knotless Surgical Sutures market.

Key Takeaways from USA Knotless Surgical Sutures Industry Study

  • Absorbable surgical sutures are the leading products and held about 61.0% market share in 2022. Absorbable sutures are commonly used for internal tissues that heal relatively quickly or in areas that are difficult to access for suture removal.
  • By raw material, polyglactin absorbable surgical sutures are the predominant type and are significantly linked to high biocompatibility, versatility and convenient handling characteristics, and held about 22.4% market share in 2022.
  • The synthetic source segment held the dominant market share of 51.3%, as it eliminated the need for tying knots, which can significantly reduce the time required for suturing.
  • Cardiovascular procedures held the dominant market share of 32.2%, as the number of cardiovascular procedures are rising in the USA
  • Hospital laboratories segment by end user accounted for a revenue share of 34.9% in the USA market at the end of 2022. Hospital laboratories are important in evaluating the performance and characteristics of various sutures which assess factors such as suture strength, biocompatibility, and tissue response
  • By state, Northeast is leading in the USA knotless sutures market and is expected to continue to do so with a projected CAGR rate of 5.0% during the forecasted years.

“Improving Patient-Centered Outcomes, Advancements in Surgical Suture Materials and Increasing Demand for Absorbable Sutures are the Key Drivers of the USA Knotless Surgical Sutures Market,” says an analyst of Future Market Insights.

USA Knotless Surgical Sutures Industry Competition

Key companies in the USA Knotless Surgical Sutures market are pursuing market expansion by utilizing growth methods like collaborations, agreements, and acquisitions. These businesses place a high priority on boosting sales efforts and using new technologies to create cutting-edge products.

  • In May 2022, Medtronic plc announced that it had successfully acquired Intersect ENT, adding cutting-edge products which are being used to treat nasal polyps and into the sinus operations to enhance post-operative outcomes and to the company’s comprehensive ENT portfolio.
  • Two new contracts for Ethicon sutures, endo-mechanicals, and trocars were announced in March 2018 by Intalere, a leader in the healthcare sector in terms of achieving optimal cost, quality, and clinical outcomes.

USA Knotless Surgical Sutures Industry Key Companies Profiled

  • Medtronic
  • Braun Melsungen AG
  • Teleflex Incorporated
  • Johnson & Johnson (Ethicon)
  • CONMED Corporation
  • Corza Medical
  • CP Medical
  • DemeTECH Corporation
  • Sutumed
  • DSI Dental Solution
  • Golnit Sutures
  • Vital Sutures
  • Atramat

A Old Full Report Analysis Click Here

Key Segments Covered in USA Knotless Surgical Sutures Industry Research

By Product:

  • Absorbable Surgical Sutures
  • Non- Absorbable Surgical Sutures

By Raw Material:

  • Polyglycolic Acid Absorbable Surgical Suture
  • Polyglactin Absorbable Surgical Sutures
  • Catgut Absorbable Surgical Sutures
  • Poliglecaprone Absorbable Surgical Sutures
  • Polydioxanone Absorbable Surgical Sutures
  • Polypropylene Non-Absorbable Surgical Sutures
  • Nylon (poylamide) Non-Absorbable Surgical Sutures
  • Polyester Non-Absorbable Surgical Sutures
  • Polyvinylidene fluoride(PVDF) Non-Absorbable Surgical Sutures
  • Silk Non-Absorbable Surgical Sutures
  • Stainless Steel Non-Absorbable Surgical Sutures

By Source:

  • Natural
  • Synthetic
    • Monofilament
    • Braided
  • Coated
  • Uncoated

By Application:

  • Cardiovascular Procedures
  • General Surgery Procedures
  • Ophthalmic Procedures
  • Orthopedic Procedures
  • Dental Procedures
  • Gastroenterology Procedures
  • Gynecology Procedures
  • Plastic Surgery Procedures
  • Veterinary Procedures

By End User:

  • Hospital Laboratories
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Veterinary Hospitals
  • Veterinary Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Veterinary Sutures Market Set to Reach USD 482.1 Million by 2033, Growing at a 3.8% CAGR

Veterinary Sutures Market
Veterinary Sutures Market

The global veterinary sutures market is poised for steady growth, with its value projected to rise from USD 333.38 million in 2023 to USD 482.1 million by 2033. This anticipated expansion represents a compound annual growth rate (CAGR) of 3.8% over the forecast period, according to recent research by Future Market Insights.

The market, which was valued at USD 323.0 million at the end of 2022, is expected to exhibit a year-on-year (Y-o-Y) growth of 3.2% in 2023. This growth trajectory reflects increasing demand for veterinary surgical procedures and advancements in suture technologies, as well as rising awareness and focus on animal healthcare.

The positive outlook for the veterinary sutures market is driven by the growing number of veterinary clinics and hospitals, advancements in surgical techniques, and a heightened emphasis on improving animal welfare and surgical outcomes.

Pet owners, in particular, are becoming more discerning about the healthcare provided to their beloved animals. This growing awareness has translated into a willingness to invest in advanced surgical procedures that can enhance their pets’ quality of life. Simultaneously, veterinary organizations worldwide are prioritizing animal welfare, actively promoting the incorporation of best practices in veterinary care.

Hence, the increasing focus on animal welfare is indeed one of the factors that are driving the growth in sales of veterinary sutures. The use of sutures is an essential part of surgical procedures for animals and is crucial for promoting faster healing and minimizing post-operative complications. By using high-quality veterinary sutures, veterinarians can ensure that animals recover from surgery as quickly and safely as possible, which is a key component of animal welfare.

As a result, the demand for high-quality veterinary sutures is increasing, as pet owners and veterinarians seek to ensure the best possible outcomes for animals undergoing surgery. Suture manufacturers are responding to this demand by developing new and improved sutures that are specifically designed for veterinary use, and by investing in research and development to advance the field of veterinary surgery.

Overall, these factors are contributing to the growth of the Global Veterinary Sutures Industry, and are expected to continue to drive demand for veterinary sutures in the coming years.

Key Takeaways from Global Veterinary Sutures Industry Study

  • Absorbable sutures are the leading segment among suture types, and held about 7 market share in 2022, due to their reduced cost and inconvenience, fewer tissue reactions, and decreased risk of long-term complications.
  • By raw material type, polyglactin absorbable surgical sutures held about 3% of the market share in 2022, polyglactin absorbable surgical sutures is a popular choice of veterinary surgeons in various surgical procedures due to their excellent handling characteristics, low inflammatory response, availability of different sizes and lengths.
  • By End User, the veterinary hospitals dominated the global veterinary sutures market withholding the total market share of about 4% by the end of 2022, owing to their larger staff and inventory of surgical supplies.
  • By region, Europe is leading in the global veterinary suture market and is expected to continue to do so with a projected CAGR rate of 9 during the forecasted years.

Global Veterinary Sutures Industry Key Companies Profiled

  • Braun
  • Ethicon
  • Medtronic Plc
  • Betatech Medical
  • Changzhou Zener Medtec
  • Gamastech
  • Génia
  • KATSAN Medical Devices
  • RWD Life Science
  • Somni Scientific
  • CP Medical
  • Vetersut
  • Vitrex Medical
  • AIP Medical SA
  • Oasis
  • GPC Medical Ltd
  • AdvaCare Pharma
  • Cortis

Global Veterinary Sutures Industry Competition

Leading players are adopting key strategies like expanding sales by launching new products and collaborations for the creation of novel products.

  • In March 2023, Animus Surgical launched a new transparent, non-toxic and biodegradable hydrogel wound sealant to replace bandages, which protects the suture lines.
  • In September 2022, Johnson & Johnson announced the news that they are establishing two independent, market-leading companies with the announcement of Kenvue. Kenvue is a new consumer healthcare company.

A Old Full Report Analysis Click Here

Key Segments Covered in Global Veterinary Sutures Industry Research

By Suture Type:

  • Absorbable Sutures
  • Non-Absorbable Sutures

By Raw Material:

  • Catgut Absorbable Surgical Sutures
  • Polyglactin Absorbable Surgical Sutures
  • Poliglecaprone Absorbable Surgical Sutures
  • Polydioxanone Absorbable Surgical Sutures
  • Polyglycolic Acid Absorbable Surgical Sutures
  • Silk Non-Absorbable Surgical Sutures
  • Nylon (poylamide) Non-Absorbable Surgical Sutures
  • Polypropylene Non-Absorbable Surgical Sutures
  • Stainless Steel Non-Absorbable Surgical Sutures
  • Others

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Clinical Research Organization Market to Surge to USD 139.6 Billion by 2033, with a 8.4% of CAGR

Clinical Research Organization
Clinical Research Organization Market

The clinical research organization (CRO) market is on a remarkable growth trajectory, with its valuation expected to escalate from USD 58.0 billion in 2022 to an impressive USD 139.6 billion by 2033, according to a recent market survey by Future Market Insights (FMI).

This substantial growth reflects the increasing demand for outsourced research services driven by the rising complexity of clinical trials, the need for cost-effective solutions, and the growing focus on personalized medicine. The CRO market’s expansion is also supported by the ongoing advancements in clinical research methodologies and the increasing number of pharmaceutical and biotechnology companies seeking specialized research support.

The projected market growth underscores the critical role CROs play in accelerating the development of new therapies and improving the efficiency of clinical trials, ultimately enhancing patient outcomes and contributing to the advancement of medical science.

The market for clinical research organizations (CROs) is expanding mostly due to the efforts of the pharmaceutical and biotechnology industries. These businesses invest a lot of money in the discovery of novel treatments and medications, and they frequently contract out some or all of the clinical research work to CROs to increase productivity and access to funding.

A great deal of financing for clinical research studies—particularly those involving new medicinal compounds—comes from pharmaceutical and biotech corporations. These businesses frequently look to collaborate with CROs who can offer specialized knowledge in research design, data administration, and general project management.

Pharmaceutical and biotech companies can shorten the time it takes to develop new drugs by outsourcing clinical trial efforts to CROs and concentrating internal resources on core research and development tasks. The CRO market will be driven by the rise in the tendency to outsource clinical development as the number of novel neurological therapeutics increases.

Investments in various pharma and life science firms are increasing as neurological illnesses become more common. The research and development of novel drugs and technologies for the treatment of various neurological illnesses, such as Alzheimer’s disease, is being heavily invested in by these businesses. Researchers have been urged to invest in early-stage advancements in neuroscience and neurology studies as a result of an increase in late-stage clinical failures in the neuroscience area in recent years.

Key Takeaways from Market Study

  • Post-approval services are the leading segment product among lasers, and held about 45.7% market share in 2022, services are crucial for ensuring the continued safety and efficacy of the product or therapy.
  • By production, In-house production is the leading segment and held 58.3% market share in 2022. As In-house clinical research offers greater control over study data and technological expertise
  • By indication, oncology segment is leading, and held 23.4% market share in 2022, being the fastest growing area in clinical research.
  • By end user, the pharmaceutical & biotechnology companies dominated the global clinical research organization market withholding the total market share of about 45.6% by the end of 2022, owing to the convenience and ease of accessibility to a range of products label products to licensed products.
  • By region, North America is leading in the global market with U.S. contributing around US$ 19.5 Billion in 2022.

“Increasing prevalence of cancer and growing awareness and diagnosis of the conditions using different oncological studies such as screening trials, interventional trials, etc. to create lucrative potential for the market to grow,” says an analyst of Future Market Insights.

Market Competition

The key market players in the market for clinical research organisations use partnerships, acquisitions, consolidations, and alliances to grow their businesses. The focus these market players is on strategies like boosting revenue and implementing cutting-edge technology for creation of novel items.

  • In October 2021, Parexel and Kyoto University Hospital, Japan announced a strategic partnership that will improve clinical research prospects. This offers effective and fruitful approaches to help clinical research in a number of therapeutic fields, including neurology.
  • In November 2021, IQVIA announced the opening of brand-new Q2 Solutions Innovation Laboratories with a cutting-edge range of laboratory capabilities in North Carolina. This will increase the company’s capabilities and generate new employment opportunities for qualified people.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the clinical research organization market in its latest study, presenting a historical demand assessment of 2018 – 2022 and projections for 2023 – 2033. The global clinical research organization market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on service (drug discovery services, pre-clinical services, clinical services, post-approval services, by production (in-house, outsourced), by indication (oncology, cns, cardiovascular diseases, metabolic disorders, immunology, respiratory, musculoskeletal disorders, hematological disorders, other), by end-user (pharmaceutical & biotechnology companies, medical device companies, governments & private firms, academic institutions, others) across seven regions of the world.

Key Players:

  • Charles River Laboratories
  • Laboratory Corporation of America Holdings
  • IQVIA Inc
  • Parexel International Corporation
  • ICON plc.
  • Medpace, Syneos Health
  • CTI Clinical Trial and Consulting Services
  • Neuroservices Alliance
  • QPS Neuropharmacology
  • MD Biosciences
  • EphyX Neuroscience

A Old Full Report Analysis Click Here

Key Segments Covered in Clinical Research Organization Industry Research

By Service:

  • Drug discovery Services
  • Pre-clinical Services
  • Clinical Services
  • Post Approval Services

By Production:

  • In-house
  • Outsourced

By Indication:

  • Oncology
  • CNS
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunology
  • Respiratory
  • Musculoskeletal Disorders
  • Hematological Disorders
  • Other

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Governments & Private Firms
  • Academic Institutions
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

 

Esophageal Implant Market to Reach USD 280.2 Million by 2033, Growing at a 6.7% CAGR

Esophageal Implant Market
Esophageal Implant Market

The global esophageal implant market is poised for significant expansion over the next decade. According to recent estimates, the market is expected to reach a valuation of USD 147.0 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2033. By the end of 2033, the market value is anticipated to exceed USD 280.2 million.

This growth is driven by advancements in medical technology, increasing prevalence of esophageal conditions, and a growing focus on improving patient outcomes. As the demand for minimally invasive solutions rises, esophageal implants are gaining traction as a preferred treatment option.

Similarly, the adoption of Esophageal Implants will be driven by technological breakthroughs and product innovation. Improved attributes, such as improved biocompatibility, durability, ease of insertion, and patient comfort, tend to increase market share and boost sales.

Compliance with regulatory requirements and regulatory approvals are required for the commercialization and selling of Esophageal Implants. Companies that have gotten all of the relevant certifications and approvals have a competitive advantage and better sales.

Reimbursement policies and coverage for Esophageal Implants have an impact on sales since they affect patients’ access to and affordability of these devices. Favourable reimbursement regulations can boost Esophageal Implant acceptance and sales.

Because of variances in healthcare infrastructure, disease incidence, economic variables, and cultural factors, demand for Esophageal Implants varies among areas and countries. Companies may need to adjust their sales strategy to target various regional areas.

Key Takeaways from the Esophageal Implant Market:

  • Global sales of Esophageal Implants are expected to surge at 6.7% CAGR through 2033.
  • Based on the product, esophageal stents segment is forecast to progress at 6.0% CAGR from 2023 to 2033.
  • By application, the gastroesophageal reflux disease (GERD) segment is poised to exhibit 7.4% CAGR through 2033.
  • By end-use, the hospital segment is anticipated to expand at a CAGR of 7.1% over the forecast duration.
  • The United States’ Esophageal Implant market value is likely to reach US$ 105.2 million by 2033.
  • The United Kingdom’s Esophageal Implant industry is estimated to reach a valuation of US$ 14.11 million by 2033.
  • Esophageal Implant demand in China is expected to increase at 8.6% CAGR through 2033.
  • Japan’s market is predicted to reach a valuation of US$ 4.4 million by 2033.
  • South Korea’s Esophageal Implant industry is poised to exhibit a 6.9% CAGR during the forecast period.

“Rising prevalence of esophageal disorders globally will create high demand for Esophageal Implants during the assessment period. To gain profits, manufacturers should focus on markets with favorable regulatory environments and operational guidelines.” – says a lead analyst at Future Market Insights (FMI)

Recent developments:

  • In 2020, Olympus started the commercial launch of the HANAROSTENT Esophagus TTS Stent.

More Insights Available:

Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the Esophageal Implant market presenting historical data (2017 to 2022) and forecast statistics for the period from 2023 to 2033.

The study reveals future market projections based on the product (esophageal stents, magnetic sphincter augmentation (MSA) devices, injectable bulking agents, and artificial esophageal valves), application (gastroesophageal reflux disease (GERD), esophageal strictures, esophageal fistulas, esophageal defects, and weakened esophageal sphincters), and end-user (hospitals, ambulatory surgical centers, specialty clinics, academic & research institutions, and weakened esophageal sphincters) across various regions.

A Old Full Report Analysis Click Here

Esophageal Implant Market Segmentation

By Product:

  • Esophageal Stents
    • Self-Expandable Metal Stents (SEMS)
    • Polymer Stents
    • Biodegradable Stents
    • Hybrid Stents
  • Magnetic Sphincter Augmentation (MSA) Devices
  • Injectable Bulking Agents
  • Artificial Esophageal Valves
    • Endoscopic Esophageal Valves
    • Prosthetic Esophageal Valves

By Application:

  • Gastroesophageal Reflux Disease (GERD)
  • Esophageal Strictures
  • Esophageal Fistulas
  • Esophageal Defects
  • Weakened Esophageal Sphincters

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics
  • Academic & Research Institutions
  • Weakened Esophageal Sphincters

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Teeth Whitening Pens Market Valued at USD 501.5 Million in 2022, Projected to Reach USD 830.9 Million by 2033 at a 4.8% CAGR

Teeth Whitening Pens Market
Teeth Whitening Pens Market

The global teeth whitening pens market is set for notable growth, with its valuation projected to increase from USD 501.5 million in 2022 to USD 830.9 million by 2033, representing a compound annual growth rate (CAGR) of 4.8%, according to a recent study by Future Market Insights.

In 2022, the slow whitening segment emerged as the dominant force within the market, holding a substantial 68.6% share of the global market. This preference reflects the growing demand for gradual, less abrasive teeth whitening solutions that cater to consumers seeking a gentler approach to achieving a brighter smile.

The anticipated market growth is driven by rising consumer awareness of oral aesthetics, increased accessibility of at-home whitening products, and advancements in whitening technologies. As more individuals seek convenient and effective solutions for enhancing their smiles, the teeth whitening pens market is expected to see sustained demand.

Rising awareness of dental hygiene and cosmetic dentistry has also contributed to the market’s growth, with consumers looking for ways to improve their appearance and boost their confidence. Dental clinics remain a major distribution channel for teeth whitening pens, offering professional guidance and recommendations to patients.

After the breakdown of COVID-19, more consumers started seeking out at-home teeth whitening options, which further fueled the market’s growth and it is expected that this trend will continue to expand the market over the forecast period. The market has lucrative opportunities for companies to expand their reach and tap into new markets through e-commerce platforms and provide wide accessibility of products to the larger consumer base.

Overall, the teeth whitening pen market is expected to continue its growth trajectory in the coming years, providing a cost-effective and convenient solution for consumers looking to enhance their smiles.

Key Takeaways:

  • Carbamide peroxide-based pens held a market share for the bleach-type segment of about 60.5% in the global market, in 2022. This is owed to their effectiveness at removing stains and discolouration while being safe for home-use
  • By whitening Pace, the slow whitening segment held a share of around 68.6% in the global market, in 2022 due to their affordability and popularity for at-home teeth whitening
  • By sensitivity type, general teeth whitening held the largest share of about 59.2% in the global market due to the convenience and affordability of general teeth whitening pens
  • By distribution channel, the dental clinics held a market share of around 28.6% in 2022 as they are able to provide professional guidance and recommendations to their patients
  • North America dominated the global market with the U.S. contributing around US$ 138.4 Millionin 2022.

“Demand for teeth whitening pens have boosted in recent years, as consumers look for ways to improve their appearance and boost their confidence,”says an analyst of Future Market Insights.

Market Competition:

The teeth whitening pen market is highly competitive, with key players including Colgate-Palmolive Company and Procter & Gamble. These companies are constantly innovating their products and marketing strategies to gain a larger market share, with a focus on affordability, convenience, and effectiveness.

  • In February 2023, SmileDirectClub, Inc., included a new Sensitivity-Free Whitening Kit to its current portfolio of affordable yet premium oral care products.
  • In September 2021, Colgate-Palmolive partnered with Verily for oral health research and development activities.

Key Companies Profiled:

  • Procter & Gamble
  • Colgate – Palmolive Company
  • Koninkiljke Phillips N.V.
  • SmileDirectClub Inc.
  • BleachBright
  • White Glo
  • Whiter Image
  • Dr Fresh LLC
  • Tarte Cosmetics
  • Cavex Holland BV
  • Spotlight Oral Care
  • Lumineux Health
  • Perfora
  • Moon Oral Care
  • GO SMILE
  • Auraglow
  • Smilebriter
  • Keeko
  • Beaming White, LLC.
  • Mr Bright Smile

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube